Biomarker for Huntington’s disease identified | Science News

Love Science? Welcome Home.

Support Amazing Science Journalism.

Create the New Science Generation.


News

Biomarker for Huntington’s disease identified

Measures of gene activity indicate illness progression, treatment effectiveness

By
2:25pm, October 4, 2011

Scientists on the trail of treatments for Huntington’s disease may have found a way to track their success. A new study reports that patients with Huntington’s disease have higher levels of expression of a gene called H2AFY in their blood compared with healthy people. What’s more, patients treated with a drug that slows the effects of the disease had reduced levels of H2AFY activity compared with people given a placebo.

The results suggest that H2AFY could serve as a tool for monitoring the progression of the disease and an indicator of whether prospective treatments are working, researchers report online October 3 in the Proceedings of the National Academy of Sciences.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News